AI assistant
Strawberry Inc. — Director's Dealing 2025
Jul 10, 2025
7062_rns_2025-07-10_757e7fc1-7859-426a-ac09-1a239bcfdb46.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
| OMB APPROVAL | |
|---|---|
| OMB Number: | 3235-0287 |
07/09/2025 09:58 AM
| OMB Number: | 3235-0287 |
|---|---|
| Estimated average burden hours per response |
0.5 |
continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant
to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
| 1. Name and Address of Reporting Person* LEVINE JACK |
2. Issuer Name and Ticker or Trading Symbol Strawberry Fields REIT, Inc. [ STRW ] |
5. Relationship of Reporting Person(s) to Issuer (Check all applicable) |
||||||
|---|---|---|---|---|---|---|---|---|
| X | Director | 10% Owner | ||||||
| (Last) | (First) | (Middle) | 3. Date of Earliest Transaction (Month/Day/Year) 07/08/2025 |
Officer (give title below) |
Other (specify below) |
|||
| 3050 BISCAYNE BLVD, SUITE 302 | ||||||||
| (Street) | 4. If Amendment, Date of Original Filed (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable | ||||||
| MIAMI | FL | 33137 | Line) X |
Form filed by One Reporting Person | ||||
| (City) | (State) | (Zip) | Form filed by More than One Reporting Person |
| Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction 2A. Deemed Date Execution Date, (Month/Day/Year) if any (Month/Day/Year) |
3. Transaction Code (Instr. 8) |
4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) |
7. Nature of Indirect Beneficial Ownership |
|||||
| Code | V | Amount | (A) or (D) |
Price | Reported Transaction(s) (Instr. 3 and 4) |
(Instr. 4) | |||||
| Common Stock | 07/08/2025 | P | 10,000 | A | \$9.92 | 130,000 | I | Cameo Life Sciences Investment, LLC |
| Table II – Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) |
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security |
3. Transaction Date (Month/Day/Year) |
3A. Deemed Execution Date, if any (Month/Day/Year) |
4. 5. Number Transaction of Code (Instr. Derivative 8) Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
|||||
| Code | V | (A) | (D) | Date Exercisable |
Expiration Date |
Title | Amount or Number of Shares |
Explanation of Responses:
/s/ Jack Levine 07/09/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.